Precision genomics is revolutionizing our understanding of disease. By analyzing an individual's unique genetic makeup, we can pinpoint potential risks and develop tailored treatment plans. This methodology holds immense promise for improving patient outcomes and propelling healthcare into a new era of specificity. Through genomic analysis, we can

. these experiments are known as mutation accumulation (MA) experiments (Elena and Lenski 2003; Lind and Andersson 2008; Brockhurst et al. 2010). It is now doable to observe up MA experiments with whole-genome sequencing of your ancestor strain and its resulting progeny, Consequently enabling to the genome-extensive identification from the MA mutat